RPS PHARMA SERVICES LTDActive

Company number 12019918Private limited companyIncorporated 2019

Key figures

£45,490+11.7%
Net assets 2025/26
+30.5%
Average annual growth 2020/21–2025/26
020 k40 k60 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, RPS PHARMA SERVICES LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Total assets33,61775,75451,32354,48573,373
Total liabilities9,12646,94819,71513,74527,883
Net assets / total equity24,49128,80631,60840,74045,490
Average number of employees02000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: RPS PHARMA SERVICES LTD

Company

RPS PHARMA SERVICES LTD is a private limited company registered with Companies House under company number 12019918. It was incorporated on 28 May 2019. Its status is active. The registered office is in Reading (RG7). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730), other letting and operating of own or leased real estate (68209), management consultancy activities other than financial management (70229), other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 May 2026); the company files micro-entity accounts. Net assets were £45,490, up 11.7% on the previous year. Total assets were £73,373 and total liabilities £27,883. The company had an average of 0 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 29 Feb 2028. The next confirmation statement is due by 13 Jun 2027.